Chemotherapy response and recurrence-free survival in neoadjuvant breast cancer depends on biomarker profiles: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657)
- Citation:
- Breast Cancer Res Treat vol 132 (3) 1049-1062
- Year:
- 2012
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Secondary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- Yes
- SDC:
- No
- Book Volume:
- 1
- Parents:
- 619
- Children:
- None
- Program:
- TRP
- Primary Committee:
- Correl Sci NOS
- Sec. Committees:
- Pharmas:
- Grants:
- CA33601, P30 CA016672, CA58207, U01 CA080098, U10 CA033601, U10 CA079778, P50 CA058207, U01 CA079778, CA079778, U10 CA080098, CA31964, CA080098
- Corr. Author:
- Authors:
- Laura J. Esserman Donald A. Berry Maggie C. U. Cheang Christina Yau Charles M. Perou Lisa Carey Angela DeMichele Joe W. Gray Kathleen Conway-Dorsey Marc E. Lenburg Meredith B. Buxton Sarah E. Davis Laura J. van't Veer Clifford Hudis Koei Chin Denise Wolf Helen Krontiras Leslie Montgomery Debu Tripathy Constance Lehman Minetta C. Liu Olufunmilayo I. Olopade Hope S. Rugo John T. Carpenter Chad Livasy Lynn Dressler David Chhieng Baljit Singh Carolyn Mies Joseph Rabban Yunni-Yi Chen Dilip Giri Alfred Au Nola Hylton
- Networks:
- Study
- CALGB-150007
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- N/A
- Keywords:
- Breast cancer, Neoadjuvant chemotherapy, Molecular biomarkers, Pathologic complete response, Medicine & Public Health, Oncology